To report an adverse event or product quality issue, please email us at reportnow@argenx.com or call us at 1-833-274-9411.
©2026 argenx | Disclaimer | Privacy Policy | Regulations | U.S. Supplemental Privacy Notice
Tim Van Hauwermeiren
Co-Founder, Non-Independent Non-Executive Director and Chairperson of the Board
Tim Van Hauwermeiren co-founded argenx in April 2008 and serves as the non-Executive Director and Chairman of the Board of Directors. He has been a member of the Board of Directors since July 2014.
Tim serves on the board of directors of Lexeo Therapeutics, Inc. and has served on the boards for iTeos Pharmaceuticals Inc. and Aelin Therapeutics, Inc.
Tim has more than 20 years of general management and business development experience across the life sciences and consumer goods sectors, including at Ablynx and Procter & Gamble. He holds a B.Sc. and M.Sc. in bioengineering from Ghent University and an Executive MBA from The Vlerick School of Management.
|
Birth Year |
1972 |
|
Nationality |
Belgium |
|
Executive / Non-Executive |
Non-Executive |
|
Date of First Appointment |
6 May 2026 |
|
Current Term |
AGM 2030 |
|
Committee Memberships |
Research & Development Committee, Remuneration & Nomination Committee |
Current Board Positions
|
# |
Organization |
|---|---|
|
1 |
Lexeo Therapeutics, Inc. |
Past Board Positions
|
# |
Organization |
|---|---|
|
1 |
iTeos Pharmaceuticals Inc., Aelin Therapeutics, Inc. |
Explore More
At argenx, every piece of the innovation story connects. See where it leads next.
Grants
Funding research, education, and initiatives that raise the standard of care.
About Us
Discover why we’re more than a unique name.
Newsroom
The latest news and press releases from argenx.
